Solarvest Announces Relocation to New Operating Facilities

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest"), announces that
Solarvest's operating division Solarvest (P.E.I.) Inc. has relocated to its
newly renovated facilities in Montague PEI. Solarvest obtained the 30,000 sq.
ft. facility on a lease to own basis and has completed improvements for the
laboratory and production facility. 


Solarvest's primary focus is Omega 3 fatty acids and the goal of research and
operations at the new facility is to increase the yields and maximize the
efficiency of the production of Omega 3 fatty acids from micro algae utilizing
Solarvest's proprietary organic process. The Omega 3 supplement market has grown
rapidly over the last ten years with the total market forecasted to grow to $15
billion by 2015, including human and animal health applications. The great
majority of this demand has been supplied by fish oil, which many believe is
ultimately unsustainable. Solarvest's algae products are sustainable, will be
grown in a clean and contained environment, and are appropriate for vegetarian,
vegan and organic diets. The organic market demand is currently not being met as
fish and krill sources of Omega 3 are not certified organic. Solarvest plans to
satisfy this need for premium organic Omega 3 with its Nanuk brand products,
which will provide the organic food processor the opportunity to enhance their
product. 


The new operating division address is 3867 Greenfield Rd., Montague, PE. C0A
1R0, Canada. 


About Solarvest BioEnergy:

Solarvest BioEnergy Inc. is an algae technology company whose algal-based
production platform provides it with an extremely flexible system capable of
being adapted to produce clean energy in the form of hydrogen and health
products such as Omega oils in an economic and environmentally sensitive manner.



The TSX Venture Exchange has neither approved nor disapproved the contents of
this news release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.


The statements made in this news release may contain forward-looking statements
that may involve a number of risks and uncertainties. Actual events or results
could differ materially from Solarvest's expectations and projections.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Solarvest BioEnergy Inc.
Gerri Greenham
Chief Executive Officer
416 420 0947
ggreenham@solarvest.ca

Solarvest BioEnergy (TSXV:SVS)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024